tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GNI Group Makes Dental Lab ZOO LABO a Consolidated Subsidiary to Bolster Japan Medtech Base
Company AnnouncementsGNI Group Makes Dental Lab ZOO LABO a Consolidated Subsidiary to Bolster Japan Medtech Base
4d ago
GNI Subsidiary Cullgen to Showcase Advancing Pipeline at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
GNI Subsidiary Cullgen to Showcase Advancing Pipeline at J.P. Morgan Healthcare Conference
5d ago
GNI Group’s F351 Secures Path Toward Conditional Approval and Priority Review in China
PremiumCompany Announcements
GNI Group’s F351 Secures Path Toward Conditional Approval and Priority Review in China
7d ago
GNI Group Exits Governance Partners ASIA Fund and Brings Key Holding On-Balance Sheet
PremiumCompany Announcements
GNI Group Exits Governance Partners ASIA Fund and Brings Key Holding On-Balance Sheet
22d ago
GNI Subsidiary Cullgen and Pulmatrix Relax Merger Terms to Seek Strategic Alternatives
PremiumCompany Announcements
GNI Subsidiary Cullgen and Pulmatrix Relax Merger Terms to Seek Strategic Alternatives
25d ago
GNI Group’s Subsidiary Reports Positive Phase 1 Trial Results for Non-Opioid Pain Treatment
PremiumCompany AnnouncementsGNI Group’s Subsidiary Reports Positive Phase 1 Trial Results for Non-Opioid Pain Treatment
29d ago
GNI Group Reports Q3 FY2025 Financial Results: Revenue Up, Profitability Down
Premium
Company Announcements
GNI Group Reports Q3 FY2025 Financial Results: Revenue Up, Profitability Down
2M ago
3G6 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
3G6 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
GNI Group’s Subsidiary Completes Enrollment for Key Clinical Trial
PremiumCompany Announcements
GNI Group’s Subsidiary Completes Enrollment for Key Clinical Trial
3M ago
GNI Group Advances Non-Opioid Pain Therapy with Phase 1 Trial Completion
PremiumCompany Announcements
GNI Group Advances Non-Opioid Pain Therapy with Phase 1 Trial Completion
4M ago
GNI Group Ltd. Expands Global Presence Through Strategic Equity Offering
PremiumCompany Announcements
GNI Group Ltd. Expands Global Presence Through Strategic Equity Offering
4M ago
GNI Group Appoints New Executive Officer to Drive Global Growth
PremiumCompany Announcements
GNI Group Appoints New Executive Officer to Drive Global Growth
5M ago
GNI Group Reports Q2 FY2025 Financial Results with Increased Revenue but Net Loss
PremiumCompany AnnouncementsGNI Group Reports Q2 FY2025 Financial Results with Increased Revenue but Net Loss
5M ago
3G6 Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
3G6 Upcoming Earnings Report: What to Expect?
5M ago
GNI Group Increases Stake in Gyre Pharmaceuticals to Boost Corporate Value
Premium
Company Announcements
GNI Group Increases Stake in Gyre Pharmaceuticals to Boost Corporate Value
5M ago
GNI Group’s Cullgen Nears Nasdaq Listing After Shareholder Approval
PremiumCompany Announcements
GNI Group’s Cullgen Nears Nasdaq Listing After Shareholder Approval
7M ago
GNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
PremiumCompany Announcements
GNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
7M ago
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
PremiumCompany Announcements
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
7M ago
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
PremiumCompany Announcements
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
8M ago
GNI Group’s Liver Fibrosis Drug Achieves Key Trial Success in China
PremiumCompany AnnouncementsGNI Group’s Liver Fibrosis Drug Achieves Key Trial Success in China
8M ago
Gyre Therapeutics Launches $20 Million Public Stock Offering
Premium
Company Announcements
Gyre Therapeutics Launches $20 Million Public Stock Offering
8M ago
GNI Group Reports Decline in Q1 FY2025 Financial Results
Premium
Company Announcements
GNI Group Reports Decline in Q1 FY2025 Financial Results
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >